a commercial weight loss program with a client base composed of 95 women experienced sporadic complaints of nausea and vomiting after changing its multivitamin supplierthis retrospective and observational study was designed to determine if related adverse event reports were significant and to investigate potential mechanism for their occurrence in this group of subjects many of whom were concurrently receiving oral contraceptives or hormone replacement therapyincidence of nausea vomiting rash and total complaints in the 3 months following the change of the multivitamin formulation was compared with the same complaints in the 3 months before the changein the 3 months following the multivitamin change there were 166 complaints of nausea and vomiting 9 complaints of rash and 194 total complaints from a group of 88468 patientsin the 3 months before the change in the multivitamin there had been 2 complaints of nausea and vomiting no complaints of rash and 11 total complaints from 88252 patientsthe difference detected by a chisquared test was significant for all events studied nausea and vomiting p  00001 rash p  002 and total complaints p  00001the altered multivitamins contained added citrus bioflavanoids not included in the original formulacitrus bioflavanoids decrease the clearance of exogenous estrogens by inhibiting cytochrome p450 enzyme systemselevated estrogen levels could account for the increased incidence of nausea and vomitingthis experience demonstrates that adding dietary herbal supplements to multivitamins may be associated with adverse interactions with prescription drugs